Development of skeletal muscle evaluation method by 99mTc-MIBI imaging for mitochondrial disease

Development of skeletal muscle evaluation method by 99mTc-MIBI imaging for mitochondrial disease - Skeletal muscle evaluation by MIBI for mitochondrial disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027882

Enrollment

Registered

2017-06-23

Start date

2017-06-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitochondrial disease

Interventions

Twice, two days (First time, half a year to one year later) 99mTc-methoxyisobutylisonitrile (MIBI)370MBq

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Certified case of mitochondrial disease certification criteria

Exclusion criteria

Exclusion criteria: 1.Subjects who are pregnant or breastfeeding 2.Subjects who are judged to be difficult to participate due to psychosis or psychiatric symptoms 3.Subjects who are judged that rest during imaging scan can not be maintained. 4.Subjects judged by doctor as maladaptive.

Design outcomes

Primary

Measure	Time frame
Characteristics of skeletal muscle distribution and degree of MIBI in mitochondrial disease	—

Countries

Japan

Contacts

Public ContactMegumi Jinguji

Kagoshima university hospital Radiology

megu@m.kufm.kagoshima-u.ac.jp099-275-5417

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026